compound of formula (I), pharmaceutical composition containing same, use thereof or pharmaceutically acceptable salt thereof and method for treating a disease mediated by motilin receptor agonistic activity in an individual mammal, including a human.

• 收藏
• 分享

专利权人:

RAQUALIA PHARMA INC.

发明人:

HIROHIDE NOGUCHI,MADOKA JINNO,MASAKI SUDO,MASASHI OHMI,YASUHIRO IWATA,YOSHIMASA ARANO

申请号：

BRPI1007962

公开号：

BRPI1007962A2

申请日:

2010.03.01

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

The present invention relates to novel oxyindole derivatives of formula (I) or a pharmaceutically acceptable salt thereof, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders which are mediated via the motilin receptor (GPR38).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/